Global Cell Lysis And Fractionation Market
Healthcare Services

Cell lysis and fractionation market forecast (2026–2030)

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Cell Lysis And Fractionation Market Projected To Reach By 2030?

The cell lysis and fractionation market has shown robust growth recently. This market is projected to expand from $3.69 billion in 2025 to $3.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has stemmed from factors such as heightened molecular biology research, a rise in proteomics investigations, the increasing adoption of nucleic acid purification methods, the proliferation of life science laboratories, and a greater need for standardized sample preparation.

The cell lysis and fractionation market is anticipated to experience substantial growth over the coming years. By 2030, its size is projected to reach $5.16 billion, expanding at a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period is largely driven by factors such as greater investments in proteomics and genomics studies, a broader uptake of automated sample preparation techniques, an intensified focus on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and an increased implementation of integrated laboratory systems. Key trends anticipated within this period involve the increasing integration of automated cell lysis systems, a surging demand for highly efficient protein extraction, the expanding application of both chemical and mechanical lysis methods, the broadening scope of fractionation-based sample preparation, and an elevated emphasis on maintaining sample integrity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Important Drivers Are Guiding The Cell Lysis And Fractionation Market Growth?

The increasing emphasis on personalized medicine is anticipated to fuel the expansion of the cell lysis and fractionation markets in the future. This innovative medical approach utilizes an individual’s genetic blueprint for disease diagnosis and treatment, customizing medical strategies and therapies based on each patient’s distinct genetic characteristics. Cell lysis and fractionation are vital for precision medicine, enabling the isolation and examination of specific subcellular components—like proteins, organelles, and nucleic acids—from patient samples. This capability empowers scientists and healthcare providers to explore the molecular underpinnings of diseases and develop bespoke treatments tailored to each patient’s distinct molecular profile. For example, data from February 2024, provided by the US-based nonprofit Personalized Medicine Coalition (PMC), indicates that in 2023, the Food and Drug Administration (FDA) sanctioned 7 new personalized cancer treatments, contributing to a total of 26 personalized treatments approved that year, which represents a notable rise compared to the 12 approvals in 2022. Consequently, this heightened attention on personalized medicine is stimulating the expansion of the cell lysis and fractionation markets.

Which Segment Categories Are Included In The Cell Lysis And Fractionation Market Segment Analysis?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

What Trends Are Influencing The Evolution Of The Cell Lysis And Fractionation Market?

Leading companies in the cell lysis and fractionation market are concentrating on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive advantage. These lysis kits provide a simplified AAV (Adeno-associated virus) lysis methodology aimed at improving SOPs (Standard Operating Procedures), quality control, and safety, while also standardizing bioprocessing workflows. For example, in July 2023, QIAGEN, a Germany-based supplier of sample and assay technologies, launched its new CGT Viral Vector Lysis Kit. This innovation allows for the quantification of virus titers for several serotypes using an exact and uniform procedure that begins with cell lysates. This new CGT viral vector lysis kit enhances QIAGEN’s rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to monitor host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

Who Are The Active Companies Shaping The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Get The Full Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Region Is The Top Contributor To The Cell Lysis And Fractionation Market By Share?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Lysis And Fractionation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Expansion Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Cell Separation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-separation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *